Advertisement
News
Subscribe to MDT Magazine News

Siemens Launches PEP, a Personalized Education Plan for Clinical Laboratory and Healthcare Professionals

January 11, 2011 5:33 am | by Bio-Medicine.Org | Comments

DEERFIELD, Ill., Jan. 11, 2011 /- Siemens Healthcare Diagnostics introduces Personalized Education Plan (PEP): the industry's first competency-based clinical laboratory education model focused exclusively on the individual. Healthcare professionals, guided by their own instructional...

TOPICS:

STAAR Surgical forecasts 4Q revenue outlook

January 11, 2011 4:45 am | by The Associated Press | Comments

Implantable eye lens maker STAAR Surgical Co. said Tuesday it expects about $14.2 million in revenue in the fourth quarter, a decrease of 28 percent from the fourth quarter of 2009.STAAR said revenue from its implantable collamer lens products grew 13 percent in the quarter and surgery volumes...

Rib-X raises $20M to develop antibiotics

January 11, 2011 4:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Rib-X Pharmaceuticals Inc., an antibiotics company in New Haven, Conn., has taken in a $20 million financing, led by Warburg Pincus LLC.

Advertisement

Microfluidics bought for $14M by IDEX

January 11, 2011 4:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Microfluidics International Corp., a Newton-based manufacturer of fluid processors has agreed to be bought by Illinois company IDEX Corp. for approximately $14 million in cash, a solid premium over Microfluidics' recent share prices.

New research aims to shut down viral assembly line

January 11, 2011 4:33 am | by EurekAlert | Comments

(Arizona State University) Brenda Hogue and her colleagues at the Biodesign Institute at Arizona State University are studying the intricate formation of coronaviruses. The research may provide fresh insights leading to antiviral agents against viral pathogens like SARS.

TOPICS:

Stereotaxis Announces CE Mark and First Human Case for Vdriveâ„¢(2)

January 11, 2011 3:37 am | by Bio-Medicine.Org | Comments

ST. LOUIS, Jan. 11, 2011 /- Stereotaxis, Inc. (Nasdaq: STXS ) announces the first successful cardiac ablation procedure with the Vdrive™ robotic navigation system as the company received CE Mark for this latest innovation.     In the first procedure with the Vdrive system,...

TOPICS:

AccessClosure Announces Launch of New Mynx Cadenceâ„¢ Vascular Closure Device

January 11, 2011 3:35 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Jan. 11, 2011 /- AccessClosure, Inc., the U.S. market leader in extravascular closure devices, announced today the launch of its next generation product, the Mynx Cadence Vascular Closure Device (VCD).  With its simpler design and improved ease-of-use, Mynx...

TOPICS:

Stereotaxis Announces CE Mark and First Human Case for Vdriveâ„¢

January 11, 2011 3:35 am | Comments

ST. LOUIS, Jan. 11, 2011 /- Stereotaxis, Inc. (Nasdaq: STXS ) announces the first successful cardiac ablation procedure with the Vdrive™ robotic navigation system as the company received CE Mark for this latest innovation.     In the first procedure with the Vdrive system,...

Advertisement

STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million

January 11, 2011 2:35 am | by Bio-Medicine.Org | Comments

MONROVIA, Calif., Jan. 11, 2011 /- STAAR Surgical Company (Nasdaq: STAA ), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it expects revenue for the fourth quarter ended December 31, 2010 to exceed $14.2 million. Revenues for...

TOPICS:

Mithridion, Inc. Announces New Funding and Outlines Strategy for Central Nervous System Drug Development

January 11, 2011 2:33 am | by Bio-Medicine.Org | Comments

MADISON, Wis. and TOLEDO, Ohio, Jan. 11, 2011 /- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding....

TOPICS:

AP Enterprise: FDA helps states get execution drug

January 11, 2011 12:45 am | by ANDREW WELSH-HUGGINS - AP Legal Affairs Writer - Associated Press | Comments

The Food and Drug Administration helped Arizona and California obtain a quick overseas source of a hard-to-find execution drug even as the agency declared it would not regulate or block imports, records show.The shortage of the drug, sodium thiopental, has disrupted executions around the country....

Decades-Long Medical Study Begins With Kickoff

January 10, 2011 10:35 pm | by San Diego Business Journal | Comments

The San Diego County component of the nation's largest long-term examination of children's health and development was launched Jan. 10.

TOPICS:

Shellfish safer to eat thanks to breakthrough by Queen's scientists

January 10, 2011 8:40 pm | by EurekAlert | Comments

(Queen's University Belfast) New technology to make shellfish safer to eat has been pioneered by scientists at Queen's University Belfast. The new test, developed at Queen's Institute for Agri-Food and Land Use, not only ensures shellfish are free of toxins before they reach the...

TOPICS:

Nationwide Children's Hospital awarded $11.5 million contract extension for biospecimen banking

January 10, 2011 8:33 pm | by EurekAlert | Comments

(Nationwide Children's Hospital) Nationwide Children's Hospital was awarded $11.5 million from the National Cancer Institute late last year to continue its role as one of two Biospecimen Core Resources for the Cancer Genome Atlas. Contract awards to Nationwide Children's could total up to...

TOPICS:

ESHRE bridges East and West for its 2012 Congress in Istanbul(3)

January 10, 2011 4:37 pm | by EurekAlert | Comments

(European Society of Human Reproduction and Embryology) The European Society of Human Reproduction and Embryology announced today that it has chosen Istanbul for its 2012 Annual Meeting. During 1 to 4 July 2012, ESHRE will hold its Annual Meeting at the Istanbul Congress Centre.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading